The Center for Applied NanoBioscience and Medicine Awarded Grant from NASA to Develop Prototype by September 2020
Amid the coronavirus pandemic, a team of researchers at the University of Arizona College of Medicine – Phoenix are developing a device that will easily and accurately detect COVID-19 in a matter of minutes.Continue reading
Author Archive: AZBio
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulatorsContinue reading
Woodbury named CEO of Science Foundation Arizona
ASU’s chief science and technology officer will lead the nonprofit, which connects researchers, businessesContinue reading
AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million
AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 MillionContinue reading
Undaunted: ASU Science forges ahead, despite worldwide crisis
The global pandemic caused by the novel coronavirus has affected nearly every aspect of daily life in Arizona and across the nation, putting many summer activities on pause in the midst of great uncertainly. But as ASU advances an ambitious agenda designed to keep the Sun Devil community safe this coming academic year, research at the Biodesign Institute marches forward.Continue reading
UArizona-TGen Led Team Identifies New Biomarkers to Diagnose and Monitor Brain Injuries
Integrated protein and metabolite analysis open the door to more precise ways of guiding treatment for the nearly 70 million people worldwide who annually suffer traumatic brain injuriesContinue reading
Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
- Promising vaccine candidate selected by U.S. government’s Operation Warp Speed
- U.S. government to provide funding up to $2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of an initial 100 million doses
- Ongoing discussions with European Commission – with France and Italy on the negotiation team – and other governments to ensure global access to a novel coronavirus vaccine
- Sanofi and GSK today announce a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine.
HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays
Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platformContinue reading
UArizona Aims to Provide Rapid Tests for First Responders, Those on Battlefields Exposed to Biothreats, Such as COVID-19
Thanks to a U.S. Department of Defense contract for as much as $9.5 million, the University of Arizona College of Medicine – Phoenix and partners aim to develop a portable device to easily and accurately detect biological threats, including the virus that causes COVID-19.Continue reading
President Trump Unveils Four Industry Related Executive Orders on Friday July 24th
- Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen
- The Fourth Executive Order, relating to “Most Favored Nations” pricing for Medicare Part B treatments is set to take effect on August 24, 2020 unless industry and the administration agree to an alternate plan.